After HER2 binding and internalization, the ADC releases MMAE, which binds beta‑tubulin to disrupt microtubules, causing mitotic arrest and apoptosis; killing depends on HER2-directed delivery (with possible bystander effect), not on tubulin as a targeting antigen.